Cue Biopharma (CUE) Interest & Investment Income (2018 - 2025)
Cue Biopharma's (CUE) quarterly Interest & Investment Income came in at $158000.0 in Q4 2025, down 45.52% year-on-year from $290000.0 in Q4 2024, and down 28.83% quarter-over-quarter from $222000.0 in Q3 2025.
Cue Biopharma (CUE) Interest & Investment Income (2018 - 2025) Analysis & Trends
Cue Biopharma has disclosed Interest & Investment Income across 8 years of filings, most recently posting $158000.0 for Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $158000.0, down 45.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $748000.0 (down 53.88% YoY), and the FY2025 annual result was $807000.0, down 50.25% from the prior year.
- Interest & Investment Income came in at $158000.0 for Q4 2025 at Cue Biopharma, down from $222000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $905000.0 in Q4 2023 to a low of $3898.0 in Q4 2021.
- The 5-year median for Interest & Investment Income is $211000.0 (2022), against an average of $308694.9.
- Across the five-year window, Interest & Investment Income slumped 95.0% in 2021 and surged 16113.44% in 2022, its largest moves.
- Cue Biopharma's Interest & Investment Income stood at $3898.0 in 2021, then soared by 16113.44% to $632000.0 in 2022, then surged by 43.2% to $905000.0 in 2023, then sank by 67.96% to $290000.0 in 2024, then plunged by 45.52% to $158000.0 in 2025.
- The last three Interest & Investment Income figures came in at $158000.0 (Q4 2025), $222000.0 (Q3 2025), and $198000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Cue Biopharma | 581.16 Mn | 553.47 Mn | - | 158,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 158,000.00 |
| Sep 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 290,000.00 |
| Sep 30, 2024 | 343,000.00 |
| Jun 30, 2024 | 427,000.00 |
| Mar 31, 2024 | 562,000.00 |
| Dec 31, 2023 | 905,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 564,000.00 |
| Mar 31, 2023 | 641,000.00 |
| Dec 31, 2022 | 632,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 88,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 3,898.00 |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 13,000.00 |